Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Intensive Care Medicine
Erschienen in: Intensive Care Medicine 9/2009

01.09.2009 | Original

Intensive care of aneurysmal subarachnoid hemorrhage: an international survey

verfasst von: Robert D. Stevens, Neeraj S. Naval, Marek A. Mirski, Giuseppe Citerio, Peter J. Andrews

Erschienen in: Intensive Care Medicine | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with aneurysmal subarachnoid hemorrhage (SAH) are routinely admitted to the intensive care unit for the management of neurological and systemic complications.

Objective

To determine the clinical practices of intensive care physicians treating SAH, and to evaluate the relationship between these practices and published evidence.

Design

Survey.

Participants

Physicians identified through the Society of Critical Care Medicine (SCCM), the European Society of Intensive Care Medicine (ESICM), and the Neurocritical Care Society (NCS).

Interventions

The research team classified published clinical research on key interventions in SAH diagnosis and therapy, and then generated a 45-item online questionnaire which was distributed to SCCM, NCS, and ESICM members.

Results

There were 626 completed surveys, 51% from the USA or Canada, 35% from Europe, and 14% from other regions. Respondents included anesthesiologists (38%), internists (29%), neurologists (14%), and neurosurgeons (8%). Agreement with selected evidence-based recommendations was variable (39–92%) and did not depend on the quality of the supporting data. Significant practice differences were noted between respondents from North America and Europe, and between those working in high and low-volume centers (respectively >40 and ≤40 SAH cases per year).

Conclusions

This study demonstrates that the practices of intensive care physicians treating SAH are heterogeneous and often at variance with available evidence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Johnston SC, Selvin S, Gress DR (1998) The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 50:1413–1418PubMed
2.
Samra SK, Giordani B, Caveney AF, Clarke WR, Scott PA, Anderson S, Thompson BG, Todd MM (2007) Recovery of cognitive function after surgery for aneurysmal subarachnoid hemorrhage. Stroke 38:1864–1872PubMedCrossRef
3.
Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, Torner JC (1995) Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 23:1007–1017PubMedCrossRef
4.
Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA (2006) Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 34:617–623 Quiz 624PubMedCrossRef
5.
Guglielmi G, Vinuela F, Dion J, Duckwiler G (1991) Electrothrombosis of saccular aneurysms via endovascular approach. Part 2: preliminary clinical experience. J Neurosurg 75:8–14PubMedCrossRef
6.
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267–1274PubMedCrossRef
7.
Todd MM, Hindman BJ, Clarke WR, Torner JC (2005) Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 352:135–145PubMedCrossRef
8.
van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ (2005) Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36:1011–1015PubMedCrossRef
9.
Feigin VL, Anderson N, Rinkel GJ, Algra A, van Gijn J, Bennett DA (2005) Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev: CD004583
10.
Dorsch NW, Kassell NF, Sinkula MS (2001) Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH. Acta Neurochir Suppl 77:233–235PubMed
11.
de Gans K, Nieuwkamp DJ, Rinkel GJ, Algra A (2002) Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery 50:336–340 discussion 340-332PubMedCrossRef
12.
Roos Y, Rinkel G, Vermeulen M, Algra A, van Gijn J (2003) Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage: a major update of a cochrane review. Stroke 34:2308–2309PubMedCrossRef
13.
Dorhout Mees SM, Rinkel GJ, Hop JW, Algra A, van Gijn J (2003) Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke 34:2285–2289PubMedCrossRef
14.
Rinkel GJ, Feigin VL, Algra A, van Gijn J (2004) Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev: CD000483
15.
Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2005) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev: CD000277
16.
Sillberg VA, Wells GA, Perry JJ (2008) Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 39:2622–2626PubMedCrossRef
17.
Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W et al (1994) Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:2315–2328PubMed
18.
Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE Jr, Harbaugh RE, Patel AB, Rosenwasser RH (2009) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994–1025PubMedCrossRef
19.
van der Schaaf IC, Ruigrok YM, Rinkel GJ, Algra A, van Gijn J (2002) Study design and outcome measures in studies on aneurysmal subarachnoid hemorrhage. Stroke 33:2043–2046PubMedCrossRef
20.
Weyer GW, Nolan CP, Macdonald RL (2006) Evidence-based cerebral vasospasm management. Neurosurg Focus 21:E8PubMedCrossRef
21.
Sakowitz OW, Raabe A, Vucak D, Kiening KL, Unterberg AW (2006) Contemporary management of aneurysmal subarachnoid hemorrhage in germany: results of a survey among 100 neurosurgical departments. Neurosurgery 58:137–145 discussion 137–145PubMedCrossRef
22.
Naval NS, Stevens RD, Mirski MA, Bhardwaj A (2006) Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med 34:511–524PubMedCrossRef
23.
Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115:e478–e534PubMedCrossRef
24.
Agresti A, Min Y (2005) Simple improved confidence intervals for comparing matched proportions. Stat Med 24:729–740PubMedCrossRef
25.
Hunt WE, Hess RM (1968) Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14–20PubMedCrossRef
26.
Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA (1997) Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients: institutional and geographical differences. J Neurosurg 86:583–588PubMedCrossRef
27.
Berman MF, Solomon RA, Mayer SA, Johnston SC, Yung PP (2003) Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 34:2200–2207PubMedCrossRef
28.
Cross DT 3rd, Tirschwell DL, Clark MA, Tuden D, Derdeyn CP, Moran CJ, Dacey RG Jr (2003) Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states. J Neurosurg 99:810–817PubMedCrossRef
29.
Cowan JA Jr, Dimick JB, Wainess RM, Upchurch GR Jr, Thompson BG (2003) Outcomes after cerebral aneurysm clip occlusion in the United States: the need for evidence-based hospital referral. J Neurosurg 99:947–952PubMedCrossRef
30.
Bardach NS, Olson SJ, Elkins JS, Smith WS, Lawton MT, Johnston SC (2004) Regionalization of treatment for subarachnoid hemorrhage: a cost-utility analysis. Circulation 109:2207–2212PubMedCrossRef
31.
32.
Bardach NS, Zhao S, Gress DR, Lawton MT, Johnston SC, Fisher WS III (2002) Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals * editorial comment. Stroke 33:1851–1856PubMedCrossRef
33.
Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev: CD000277
34.
Fernandez A, Schmidt JM, Claassen J, Pavlicova M, Huddleston D, Kreiter KT, Ostapkovich ND, Kowalski RG, Parra A, Connolly ES, Mayer SA (2007) Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology 68:1013–1019PubMedCrossRef
35.
Wurm G, Tomancok B, Nussbaumer K, Adelwohrer C, Holl K (2004) Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg 106:97–103PubMedCrossRef
36.
Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R (2003) No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 99:953–959PubMedCrossRef
37.
Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J, Georgiadis A, Selman WR (2004) Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med 32:2311–2317PubMed
38.
Patel HC, Menon DK, Tebbs S, Hawker R, Hutchinson PJ, Kirkpatrick PJ (2002) Specialist neurocritical care and outcome from head injury. Intensive Care Med 28:547–553PubMedCrossRef
39.
Mirski MA, Chang CW, Cowan R (2001) Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care: evidence-based support for an intensivist-directed specialty ICU model of care. J Neurosurg Anesthesiol 13:83–92PubMedCrossRef
40.
Varelas PN, Conti MM, Spanaki MV, Potts E, Bradford D, Sunstrom C, Fedder W, Hacein Bey L, Jaradeh S, Gennarelli TA (2004) The impact of a neurointensivist-led team on a semiclosed neurosciences intensive care unit. Crit Care Med 32:2191–2198PubMed
41.
Naidech AM, Janjua N, Kreiter KT, Ostapkovich ND, Fitzsimmons BF, Parra A, Commichau C, Connolly ES, Mayer SA (2005) Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 62:410–416PubMedCrossRef
42.
Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE (2002) Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 97:771–778PubMedCrossRef
43.
Anderson GB, Steinke DE, Petruk KC, Ashforth R, Findlay JM (1999) Computed tomographic angiography versus digital subtraction angiography for the diagnosis and early treatment of ruptured intracranial aneurysms. Neurosurgery 45:1315–1320 discussion 1320-1312PubMedCrossRef
44.
Agid R, Lee SK, Willinsky RA, Farb RI, terBrugge KG (2006) Acute subarachnoid hemorrhage: using 64-slice multidetector CT angiography to “triage” patients’ treatment. Neuroradiology 48:787–794PubMedCrossRef
45.
Westerlaan HE, Gravendeel J, Fiore D, Metzemaekers JD, Groen RJ, Mooij JJ, Oudkerk M (2007) Multislice CT angiography in the selection of patients with ruptured intracranial aneurysms suitable for clipping or coiling. Neuroradiology 49:997–1007PubMedCrossRef
46.
Ohman J, Heiskanen O (1989) Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J Neurosurg 70:55–60PubMedCrossRef
47.
Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, Sandercock P (2005) International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366:809–817PubMedCrossRef
48.
Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, Connolly ES, Mayer SA, Fitzsimmons BF (2005) Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 36:583–587PubMedCrossRef
49.
Rosengart AJ, Huo JD, Tolentino J, Novakovic RL, Frank JI, Goldenberg FD, Macdonald RL (2007) Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 107:253–260PubMedCrossRef
50.
Mack WJ, Ducruet AF, Hickman ZL, Kalyvas JT, Cleveland JR, Mocco J, Schmidt M, Mayer SA, Connolly ES Jr (2008) Doppler ultrasonography screening of poor-grade subarachnoid hemorrhage patients increases the diagnosis of deep venous thrombosis. Neurol Res 30:889–892PubMedCrossRef
51.
Frontera JA, Fernandez A, Claassen J, Schmidt M, Schumacher HC, Wartenberg K, Temes R, Parra A, Ostapkovich ND, Mayer SA (2006) Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 37:199–203PubMedCrossRef
52.
Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G (2007) The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 19:156–160PubMedCrossRef
53.
Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le Roux P, Mayer SA (2008) Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 36:3233–3238PubMedCrossRef
54.
Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ (2006) Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 59:775–779 discussion 779–780PubMedCrossRef
55.
Smith MJ, Le Roux PD, Elliott JP, Winn HR (2004) Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 101:1–7PubMedCrossRef
56.
Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP (2008) Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med 36:2070–2075PubMedCrossRef
57.
Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH (1983) Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery 12:658–661PubMedCrossRef
58.
Egge A, Waterloo K, Sjoholm H, Solberg T, Ingebrigtsen T, Romner B (2001) Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 49:593–605 discussion 605–596PubMedCrossRef
59.
Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA (2000) Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31:383–391PubMed
60.
Treggiari MM, Walder B, Suter PM, Romand JA (2003) Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978–984PubMedCrossRef
61.
Pronovost PJ, Berenholtz SM, Needham DM (2008) Translating evidence into practice: a model for large scale knowledge translation. BMJ 337:a1714PubMedCrossRef
Metadaten
Titel
Intensive care of aneurysmal subarachnoid hemorrhage: an international survey
verfasst von
Robert D. Stevens
Neeraj S. Naval
Marek A. Mirski
Giuseppe Citerio
Peter J. Andrews
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 9/2009
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-009-1533-1

Weitere Artikel der Ausgabe 9/2009

Intensive Care Medicine 9/2009 Zur Ausgabe

Legal and Ethical Issues in Clinical Research

Research ethics committees in Europe: trials and tribulations

Original

The educational environment for training in intensive care medicine: structures, processes, outcomes and challenges in the European region

Correspondence

An unexpected hazard of indwelling temperature monitoring

Case Discussion

Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report

Original

Relationships among haemoglobin level, packed red cell transfusion and clinical outcomes in patients after cardiac surgery

Original

Incidence and risk factors for ventilator-associated pneumonia after major heart surgery

Neu im Fachgebiet AINS

Sechs Maßnahmen gegen Regelschmerzen – von Krafttraining bis Yoga

05.06.2024 Dysmenorrhö Nachrichten

Um herauszufinden, wie gut sich körperliche Übungen dafür eignen, primäre Dysmenorrhö zu lindern, hat eine Studiengruppe sechs verschiedene Verfahren untersucht. Alle wirkten, doch eine Methode war Favorit.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Intoxikation ohne Alkoholaufnahme: An das Eigenbrauer-Syndrom denken!

05.06.2024 Internistische Diagnostik Nachrichten

Betrunken trotz Alkoholabstinenz? Der Fall einer 50-jährigen Patientin zeigt, dass dies möglich ist. Denn die Frau litt unter dem Eigenbrauer-Syndrom, bei dem durch Darmpilze eine alkoholische Gärung in Gang gesetzt wird.

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise